Correlation Between Geron and United Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Geron and United Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Geron and United Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Geron and United Therapeutics, you can compare the effects of market volatilities on Geron and United Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Geron with a short position of United Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Geron and United Therapeutics.

Diversification Opportunities for Geron and United Therapeutics

0.48
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Geron and United is 0.48. Overlapping area represents the amount of risk that can be diversified away by holding Geron and United Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on United Therapeutics and Geron is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Geron are associated (or correlated) with United Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of United Therapeutics has no effect on the direction of Geron i.e., Geron and United Therapeutics go up and down completely randomly.

Pair Corralation between Geron and United Therapeutics

Given the investment horizon of 90 days Geron is expected to under-perform the United Therapeutics. In addition to that, Geron is 1.33 times more volatile than United Therapeutics. It trades about -0.22 of its total potential returns per unit of risk. United Therapeutics is currently generating about -0.04 per unit of volatility. If you would invest  37,402  in United Therapeutics on November 1, 2024 and sell it today you would lose (2,172) from holding United Therapeutics or give up 5.81% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Geron  vs.  United Therapeutics

 Performance 
       Timeline  
Geron 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Geron has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in March 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
United Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days United Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable technical indicators, United Therapeutics is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.

Geron and United Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Geron and United Therapeutics

The main advantage of trading using opposite Geron and United Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Geron position performs unexpectedly, United Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in United Therapeutics will offset losses from the drop in United Therapeutics' long position.
The idea behind Geron and United Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Other Complementary Tools

ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Commodity Directory
Find actively traded commodities issued by global exchanges